Secondary analyses were performed on data from two randomized controlled trials of a cognitive behavioral therapy (CBT) program for posttraumatic stress disorder (PTSD) in individuals with severe mental illness (SMI) to examine the feasibility, tolerability, and effectiveness for individuals with borderline personality disorder (BPD). In Study 1, 27 participants received CBT or treatment as usual. In Study 2, 55 participants received CBT or a Brief treatment. Feasibility and tolerability of CBT, PTSD symptoms, and other mental health and functional outcomes were examined, with assessments at baseline, post-treatment, and two follow-up time points. CBT was feasible and tolerable in this population. Study 1 participants in CBT improved significantly more in PTSD symptoms, depression, and self-reported physical health. Study 2 participants in both CBT and Brief improved significantly in PTSD symptoms, posttraumatic cognitions, depression, and overall functioning, with those in CBT acquiring significantly more PTSD knowledge, and having marginally significantly greater improvement in PTSD symptoms. CBT for PTSD was feasible and tolerated in individuals with SMI, BPD, and PTSD, and associated with improvements in PTSD symptoms and related outcomes. Prospective research is needed to evaluate CBT in individuals with BPD, including comparing it with staged interventions for this population.
Introduction
The development of borderline personality disorder (BPD) is thought to be molded by early traumatic experiences (Golier et al., 2003) . BPD is thus frequently comorbid with posttraumatic stress disorder (PTSD), with the diagnostic overlap reported to be between 33% and 79% (Frías and Palma, 2015) . Individuals with PTSD and cooccurring BPD have more severe PTSD symptoms than those with PTSD and other comorbid disorders (Bolton et al., 2006) , leading to greater impairment, a worse prognosis, and higher healthcare utilization (Connor et al., 2002; Frías and Palma, 2015) .
Despite the high prevalence of PTSD in individuals with BPD, treatment research on this comorbid population has lagged. Current recommendations suggest stage-based approaches for the treatment of PTSD in individuals with BPD and PTSD, with the stabilization of symptoms and affect regulation prioritized before moving onto traumafocused treatment (Cloitre et al., 2012) . These recommendations have been recently challenged, based on the limited evidence supporting staged approaches, and the need for further research on the effects of more conventional approaches to PTSD (e.g., cognitive restructuring or prolonged exposure) has been emphasized (de Jongh et al., 2016) .
Recent research points to the promise of non-staged treatment approaches for vulnerable populations with PTSD. Two randomized controlled trials have demonstrated that a cognitive behavioral therapy (CBT) program based on cognitive restructuring is well tolerated and effective for individuals with both severe mental illness (i.e., schizophrenia, schizoaffective disorder, severe major depression, and bipolar disorder) and PTSD (Mueser et al., 2008 (Mueser et al., , 2015 . As such, cognitive restructuring may also be tolerated well in individuals with comorbid PTSD and BPD, many of whom also have other severe mental illnesses (Skodol et al., 2002) . Furthermore, one randomized controlled trial reported similar benefits for prolonged exposure therapy and eye movement desensitization and reprocessing therapy in persons with psychotic disorders and PTSD (van den Berg et al., 2015a) . Additionally, studies conducted in PTSD populations with complex presentations and comorbidities, in which participants with personality disorders were not excluded, have demonstrated the efficacy of prolonged exposure and cognitive processing therapy (e.g., Chard, 2005; see de Jongh et al. (2016) 
for review).
Although two studies have examined how persons with borderline characteristics fare in conventional CBT for PTSD, they were limited either the lack of a full diagnostic assessment of BPD (Clarke et al., 2008) or by small sample size (Feeny et al., 2002) . In addition, both studies were efficacy trials conducted in academic settings with stringent exclusion criteria (e.g., current suicidal ideation, severe mental illness). To our knowledge, no studies have examined CBT for individuals with comorbid BPD and PTSD in the context of an effectiveness trial targeting a more severely ill population with minimal exclusion criteria for participation.
In this paper, we retrospectively examined the feasibility, tolerability, and clinical outcomes of individuals with severe mental illness, PTSD, and BPD who participated in two randomized controlled trials evaluating a CBT program based on cognitive restructuring for vulnerable individuals with PTSD. As these trials were conducted in community mental health centers with a severe mental illness population, they present a unique opportunity to examine the benefits of CBT for PTSD within a particularly severe sample of persons with comorbid BPD. Although limited research has focused on BPD in the context of severe mental illness (Bolton et al., 2006) , it is highly comorbid with both major depression and bipolar disorder (Grant et al., 2008) . Considering these high rates of comorbidity, and the high distress and persistent life interference associated with both BPD and severe mental illness, a CBT for PTSD program designed for the severe mental illness population could be particularly beneficial to people who also have BPD. We hypothesized that the CBT for PTSD program would be feasible and tolerable in this comorbid sample of persons with PTSD, severe mental illness and BPD and that participants who received CBT would show clinical improvements in PTSD symptoms and knowledge of PTSD compared to control groups.
Methods
Secondary analyses were conducted on persons with BPD who had participated in two randomized controlled trials evaluating a CBT for PTSD program in individuals with severe mental illness and PTSD. Study 1 (Mueser et al., 2008) compared CBT with treatment as usual (TAU). Study 2 (Mueser et al., 2015) , compared CBT with a brief, 3-session intervention (Nishith et al., 2015) . Both studies were conducted at routine, publically funded mental health centers and included obtaining informed consent from participants. All procedures were approved by Institutional Review Boards of the respective institutions. Detailed descriptions of the procedures for both studies are provided elsewhere (Mueser et al., 2008 (Mueser et al., , 2015 .
Participants
The inclusion criteria for both studies were: age 18 or older; severe mental illness diagnosis (i.e., DSM-IV major depression, bipolar disorder, schizoaffective disorder, or schizophrenia and meeting of NH, VT, or NJ state criteria for severe mental illness); and current DSM-IV diagnosis of PTSD. In addition, Study 2 required that participants meet criteria for severe PTSD (i.e., Clinician Administered PTSD Scale score ≥65; Weathers et al., 1999) . The exclusion criteria for both studies were: psychiatric hospitalization or suicide attempt in the past 3 months, and current substance dependence. In both studies, participants were not excluded based on selfinjurious or parasuicidal behavior, suicidal ideation, or suicidal intent.
A total of 108 individuals participated in Study 1, of which the current analyses examined 27 individuals who met criteria for BPD, of whom 15 were randomized to CBT and 12 to TAU. A total of 201 individuals participated in Study 2, of which the current analyses examined 55 individuals with BPD, of whom 29 were randomized to 34.0 ± 9.1 38.4 ± 6.6 CAPS hyperarousal 27.0 ± 6.3 27.1 ± 5.9 PTSD knowledge score 10.1 ± 2.9 10.0 ± 2.5 PTCI total 3.9 ± 1.1 4.7 ± 0.9 BDI-II total 34.7 ± 12.9 35.0 ± 11.8 BDI-II suicidality item 0 ("I don't have any thoughts of killing myself") 41% (n=11) 44% (n=24) 1 ("I have thoughts of killing myself, but I would not carry them out") 52% (n=14) 44% (n=24) 2 ("I would like to kill myself") 7% (n=2) 4% (n=2) 3 ("I would kill myself if I had the chance") 0% (n=0) 5% (n=3) BAI total 52.3 ± 13.7 33.4 ± 15.3
Treatment information Study 1 Study 2 Randomization CBT 54% (n=15) 53% (n=29) TAU 46% (n=12) n/a Brief n/a 47% (n=26) Exposed to treatment (CBT) 85.7% (n=12) 74% (n=20) Exposed to treatment (Brief) n/a 87% (n=20)
